Avanos Medical AVNS Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 50%-0.4pp | 50.5%-1.8pp | 52.3%-1.6pp | 53.8%-0.8pp | 54.6%-0.8pp | |
| Operating margin | -9.1%0.0pp | -9.1%+59.8pp | -69%-1.0pp | -68%-11.4pp | -56.6%+1.0pp | |
| Net margin | -10.4%0.0pp | -10.4%+56.6pp | -67%-0.1pp | -66.9%-11.1pp | -55.8%+1.2pp | |
| Returns | ||||||
| Return on equity | -9.2%-0.1pp | -9.1%+37.6pp | -46.7%-0.4pp | -46.4%-9.2pp | -37.2%+0.8pp | |
| Return on invested capital | -7.5%0.0pp | -7.5%+36.7pp | -44.2%-0.8pp | -43.4%-8.7pp | -34.7%+0.6pp | |
| Efficiency | ||||||
| Asset turnover | 0.7×0.0× | 0.6×+0.1× | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | |
| Liquidity | ||||||
| Current ratio | 2.5×+0.3× | 2.2×-0.2× | 2.4×-0.3× | 2.6×+0.1× | 2.6×+0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Per Share | ||||||
| Book value per share | $16.47-2.0% | $16.81+0.2% | $16.770.0% | $16.77-6.5% | $17.94-0.4% | |
| Valuation | ||||||
| Market capitalization | $1.17B+108% | $521.28M-2.8% | $536.41M-6.3% | $572.5M-13.2% | $659.23M-9.9% | |
| Price / sales | 1.6×+0.8× | 0.7×0.0× | 0.8×-0.1× | 0.8×-0.1× | 1×-0.1× | |
| Price / book | 1.5×+0.8× | 0.7×0.0× | 0.7×0.0× | 0.7×0.0× | 0.8×-0.1× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Avanos Medical's profit margins?
- Avanos Medical (AVNS) runs a 50.0% gross margin and a -9.1% operating margin, with a -10.4% net margin.
- Where do Avanos Medical's ratios come from?
- Every ratio is computed from Avanos Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
